on September 2, 2004
Published online before print September 2, 2004, doi: 10.1161/01.ATV.0000144016.85221.66
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 17, 2003
Accepted on July 13, 2004
Enzymatic Modification of Low-Density Lipoprotein in the Arterial Wall. A New Role for Plasmin and Matrix Metalloproteinases in Atherogenesis
Michael Torzewski ;
From the Institutes of Clinical Chemistry and Laboratory Medicine (M.T., V.O., A.S., K.J.L.) and Medical Microbiology and Hygiene (P.S., K.P., L.S., S.-R.H., M.H., S.B.), and the Department of Ophthalmology (V.B.G.), University of Mainz, Germany.
* To whom correspondence should be addressed. E-mail: sbhakdi{at}uni-mainz.de.
Objective--Functionally interactive proteases of the plasminogen/plasmin and the matrix metalloproteinase (MMP) system degrade and reorganize the extracellular matrix of the vessel wall in atherosclerosis. Here we investigated whether such proteases are able to confer atherogenic properties onto low density lipoprotein by nonoxidative modification.
Methods and Results--Similar to the recently described enzymatically-modified low-density lipoprotein (E-LDL), native LDL exposed to plasmin or matrix MMP-2 or MMP-9 and cholesterylester-hydrolase (CEH) showed extensive deesterification, with ratios of free cholesterol to total cholesterol rising to 0.8 compared with 0.2 in native LDL. When the ratio exceeded 0.6, both plasmin/CEH-LDL and MMP/CEH-LDL fused into larger particles. In parallel, they gained C-reactive protein-dependent complement-activating capacity. E-LDL produced with any protease/CEH combination was efficiently taken up by human macrophages, whereby marked induction of MMP-2 expression by E-LDL was observed. These in vitro findings had their in vivo correlates: urokinase-type plasminogen activator, MMP-2, and MMP-9 were detectable in both early and advanced human atherosclerotic lesions in colocalization with E-LDL.
Conclusions--Plasmin and MMP-2/MMP-9 may not only be involved in remodeling of the extracellular matrix in progressing plaques, but they may also be involved in lipoprotein modification during genesis and progression of atherosclerotic lesions.
Key words: atherosclerosis • lipoproteins • macrophages • metalloproteinases • plasminogen activators
This article has been cited by other articles:
 |
|
 |
|
  M. Kremen, R. Krishnan, I. Emery, J. H. Hu, K. I. Slezicki, A. Wu, K. Qian, L. Du, A. Plawman, A. Stempien-Otero, et al. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice PNAS, November 4, 2008; 105(44): 17109 - 17114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Houard, A. Leclercq, V. Fontaine, M. Coutard, J.-L. Martin-Ventura, B. Ho-Tin-Noe, Z. Touat, O. Meilhac, and J.-B. Michel Retention and Activation of Blood-Borne Proteases in the Arterial Wall: Implications for Atherothrombosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A3 - A9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lee, F. Forudi, G. M. Saidel, and M. S. Penn Alterations in Internal Elastic Lamina Permeability As a Function of Age and Anatomical Site Precede Lesion Development in Apolipoprotein E-Null Mice Circ. Res., September 2, 2005; 97(5): 450 - 456. [Abstract] [Full Text] [PDF]
|
|